News
AZ/Merck & Co reveal data supporting PARP drug in prostate c...
PARP, or poly (ADP-ribose) polymerase, inhibitors may have an amusing-sounding name but an increasing body of evidence suggest they could be used in a wide range of cancers as long as certa
